
Oncophos 500mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Cyclophosphamide (500mg)
Overview Oncophos 500mg Injection
Nephro-oncological agent Oncophos (500mg injection) combats various cancers and, following unsuccessful alternative therapies, pediatric nephrotic syndrome. Its application may extend to other conditions as directed by a physician. Administered intravenously by a healthcare professional, ideally at a consistent daily time, dosage and frequency are determined individually by your doctor based on your condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. While benefits may take weeks or months to manifest, discontinuation should only occur under medical guidance. Common side effects include emesis, nausea, alopecia, pyrexia, and hematuria; persistent or worsening symptoms warrant immediate medical attention. Preventive or mitigating measures may be available. As a potent medication, serious adverse events are possible, including immunosuppression and potential complications affecting hematological, hepatic, or renal function. Regular blood monitoring is essential. Increased fluid intake is recommended to promote urinary excretion, thereby safeguarding renal health. Prior to commencing treatment, disclose any pre-existing hepatic or renal impairment, or concurrent antimicrobial therapy. Interaction with other medications is possible; provide your physician with a complete medication list. Use during pregnancy or breastfeeding is contraindicated, and reliable contraception is advised for both partners throughout the treatment period.
Primary Ingredients of Oncophos 500mg Injection
No information provided. Please provide the text you want me to rewrite.
Uses of Oncophos 500mg Injection
Malignancy | Nephrotic disorder
Major Benefits of Oncophos 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Oncophos 500mg Injection:
- Vomiting
- Nausea
- Hair loss
- Fever
- Blood in urine
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Oncophos 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Oncophos 500mg Injection works:
Injection Oncophos 500mg is a cancer treatment. Its mechanism involves alkylation, disrupting the DNA and RNA of cancerous cells, thus inhibiting their proliferation and growth. This is its anticancer action.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while using Oncophos 500mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Oncophos 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Oncophos 500mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Oncophos 500mg Injection might induce adverse reactions, potentially impairing driving capabilities. These reactions may include dizziness, blurred vision, or visual disturbances, all of which could compromise safe driving.
KidneyCAUTION
The use of Oncophos 500mg Injection requires careful consideration in individuals with significant kidney impairment. Dosage modification of Oncophos 500mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
The administration of Oncophos 500mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modifications for Oncophos 500mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Oncophos 500mg Injection :
NA
Facts to Know About Oncophos 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Alkylating Agents (Nitrogen Mustard Class) |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Alkylating substance |
